{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:21:36Z","timestamp":1794558096564,"version":"4.9.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Anadolu University Scientific Research Project Commission","award":["Project number: 2304S027, Project ID: 1956"],"award-info":[{"award-number":["Project number: 2304S027, Project ID: 1956"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-95792-3","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T11:43:11Z","timestamp":1744803791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Development of donepezil hydrochloride-loaded PLGA-based nanoparticles for Alzheimer\u2019s disease treatment"],"prefix":"10.1038","volume":"15","author":[{"given":"Merve","family":"K\u00f6m\u00fcr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fclya Tuba","family":"K\u0131yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Alper","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"95792_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41582-024-00940-4","volume":"20","author":"AD Korczyn","year":"2024","unstructured":"Korczyn, A. D. & Grinberg, L. T. Is alzheimer disease a disease? Nat. Rev. Neurol. 20, 245\u2013251 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"95792_CR2","doi-asserted-by":"crossref","unstructured":"Better, M. A. Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 20, 3708\u20133821 (2024).","DOI":"10.1002\/alz.13809"},{"key":"95792_CR3","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","volume":"29","author":"WK Self","year":"2023","unstructured":"Self, W. K. & Holtzman, D. M. Emerging diagnostics and therapeutics for alzheimer disease. Nat. Med. 29, 2187\u20132199 (2023).","journal-title":"Nat. Med."},{"key":"95792_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman, R. J. et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N. Engl. J. Med. 367, 795\u2013804 (2012).","journal-title":"N. Engl. J. Med."},{"key":"95792_CR5","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jalz.2019.04.001","volume":"15","author":"L Vermunt","year":"2019","unstructured":"Vermunt, L. et al. Duration of preclinical, prodromal, and dementia stages of alzheimer\u2019s disease in relation to age, sex, and APOE genotype. Alzheimer\u2019s Dement. 15, 888\u2013898 (2019).","journal-title":"Alzheimer\u2019s Dement."},{"key":"95792_CR6","doi-asserted-by":"crossref","unstructured":"Tzioras, M., McGeachan, R. I.,  Durrant, C. S. & Spires-Jones, T. L. Synaptic degeneration in alzheimer disease. Nat. Rev. Neurol. 19, 19\u201338 (2023).","DOI":"10.1038\/s41582-022-00749-z"},{"key":"95792_CR7","first-page":"1403","volume":"83","author":"BT Winslow","year":"2011","unstructured":"Winslow, B. T., Onysko, M. K., Stob, C. M. & Hazlewood, K. A. Treatment of alzheimer disease. Am. Fam Physician. 83, 1403\u20131412 (2011).","journal-title":"Am. Fam Physician"},{"key":"95792_CR8","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1016\/j.biomaterials.2006.12.016","volume":"28","author":"P Zhang","year":"2007","unstructured":"Zhang, P. et al. In vitro and in vivo evaluation of donepezil-sustained release microparticles for the treatment of Alzheimer\u2019s disease. Biomaterials 28, 1882\u20131888 (2007).","journal-title":"Biomaterials"},{"key":"95792_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1021\/acschemneuro.8b00517","volume":"10","author":"JT Brewster","year":"2018","unstructured":"Brewster, J. T., Dell\u2019Acqua, S., Thach, D. Q. & Sessler, J. L. Classics in chemical neuroscience: donepezil. ACS Chem. Neurosci. 10, 155\u2013167 (2018).","journal-title":"ACS Chem. Neurosci."},{"key":"95792_CR10","first-page":"183","volume":"14","author":"T Liu","year":"2019","unstructured":"Liu, T. et al. A donepezil\/cyclodextrin complexation orodispersible film: Effect of cyclodextrin on taste-masking based on dynamic process and in vivo drug absorption. Asian J. Pharm. Sci. 14, 183\u2013192 (2019).","journal-title":"Asian J. Pharm. Sci."},{"key":"95792_CR11","doi-asserted-by":"crossref","unstructured":"Tripathi, S. K. et al. Donepezil loaded PLGA Nanoparticles, from modified nano-precipitation, an advanced drug delivery system to treat Alzheimer disease. J. Phys.: Conf. Seri. 1849 12001 (2021).","DOI":"10.1088\/1742-6596\/1849\/1\/012001"},{"key":"95792_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jpba.2005.10.017","volume":"41","author":"K Nakashima","year":"2006","unstructured":"Nakashima, K., Itoh, K., Kono, M., Nakashima, M. N. & Wada, M. Determination of donepezil hydrochloride in human and rat plasma, blood and brain microdialysates by HPLC with a short C30 column. J. Pharm. Biomed. Anal. 41, 201\u2013206 (2006).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"95792_CR13","doi-asserted-by":"publisher","first-page":"33032","DOI":"10.1021\/acsnano.4c05693","volume":"18","author":"Q Zhang","year":"2024","unstructured":"Zhang, Q. et al. Multi targeted therapy for Alzheimer\u2019s disease by guanidinium-modified calixarene and cyclodextrin co-assembly loaded with insulin. ACS Nano  18, 33032\u201333041 (2024).","journal-title":"ACS Nano"},{"key":"95792_CR14","doi-asserted-by":"crossref","unstructured":"Karati, D. et al. Glycogen synthase kinase 3 (GSK3) Inhibition: A potential therapeutic strategy for Alzheimer\u2019s disease. Naunyn Schmiedebergs Arch. Pharmacol. 1\u201324 (2024).","DOI":"10.1007\/s00210-024-03500-1"},{"key":"95792_CR15","doi-asserted-by":"crossref","unstructured":"Meur, S. & Karati, D. Fyn kinase in Alzheimer\u2019s disease: Unraveling molecular mechanisms and therapeutic implications. Mol. Neurobiol. 1\u201318 (2024).","DOI":"10.1007\/s12035-024-04286-2"},{"key":"95792_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fphar.2019.00395","volume":"10","author":"H Luo","year":"2019","unstructured":"Luo, H. et al. Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat model of Alzheimer\u2019s disease through activation of BDNF-TrkB signaling pathway. Front. Pharmacol. 10, 395 (2019).","journal-title":"Front. Pharmacol."},{"key":"95792_CR17","doi-asserted-by":"publisher","first-page":"990307","DOI":"10.3389\/fphar.2022.990307","volume":"13","author":"H Li","year":"2022","unstructured":"Li, H. et al. Untargeted metabolomics analysis of the hippocampus and cerebral cortex identified the neuroprotective mechanisms of Bushen Tiansui formula in an a\u03b225-35-induced rat model of Alzheimer\u2019s disease. Front. Pharmacol. 13, 990307 (2022).","journal-title":"Front. Pharmacol."},{"key":"95792_CR18","doi-asserted-by":"publisher","first-page":"136895","DOI":"10.1016\/j.snb.2024.136895","volume":"424","author":"H Wang","year":"2025","unstructured":"Wang, H. et al. A strategy of monitoring acetylcholinesterase and screening of natural inhibitors from uncaria for Alzheimer\u2019s disease therapy based on near-infrared fluorescence probe. Sens. Actuators B Chem. 424, 136895 (2025).","journal-title":"Sens. Actuators B Chem."},{"key":"95792_CR19","doi-asserted-by":"crossref","unstructured":"Solak, B., Soyer, P., Tilki, E. K. & \u00d6zt\u00fcrk, A. A. Evaluation of antimicrobial properties and antioxidant activity of rosmarinic acid-loaded resomer RG 502 H-based nanoparticles against tert-butyl hydroperoxide-induced oxidative stress: A detailed formulation, characterization and efficacy determination study. J. Drug Deliv Sci. Technol. 106721 (2025).","DOI":"10.1016\/j.jddst.2025.106721"},{"key":"95792_CR20","doi-asserted-by":"publisher","first-page":"103961","DOI":"10.1016\/j.mvr.2019.103961","volume":"128","author":"AA \u00d6zt\u00fcrk","year":"2020","unstructured":"\u00d6zt\u00fcrk, A. A. & K\u0131yan, H. T. Treatment of oxidative stress-induced pain and inflammation with dexketoprofen trometamol loaded different molecular weight chitosan nanoparticles: Formulation, characterization and anti-inflammatory activity by using in vivo HET-CAM assay. Microvasc Res. 128, 103961 (2020).","journal-title":"Microvasc Res."},{"key":"95792_CR21","doi-asserted-by":"crossref","unstructured":"\u00d6zt\u00fcrk, A. A., Yenilmez, E. & \u00d6zarda, M. G. Clarithromycin-loaded Poly (lactic-co-glycolic acid) (PLGA) nanoparticles for oral administration: Effect of polymer molecularweight and surface modification with chitosan on formulation, nanoparticle characterization and antibacterial effects. Polym. (Basel) 11, (2019).","DOI":"10.3390\/polym11101632"},{"key":"95792_CR22","first-page":"1730","volume":"37","author":"AA \u00d6zt\u00fcrk","year":"2018","unstructured":"\u00d6zt\u00fcrk, A. A., Banderas, L. M., Otero, C., Yenilmez, M. D., Yazan, Y. & E. & New approach to hypertension treatment: Carvediol-Loaded PLGA nanoparticles, preparation, in vitro characterization and gastrointestinal stability. Lat Am. J. Pharm. 37, 1730\u20131771 (2018).","journal-title":"Lat Am. J. Pharm."},{"key":"95792_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.55971\/EJLS.1197082","volume":"1","author":"B Kaval","year":"2023","unstructured":"Kaval, B., \u015een, F. D., Batmaz, K. K., Ekinci, M. & \u00d6zt\u00fcrk, A. A. Latest research about active pharmaceutical ingredient loaded poly lactic acid-co-glycolic acid (PLGA) based drug delivery system in T\u00fcrkiye. Eur. J. Life Sci. 1, 127\u2013139 (2023).","journal-title":"Eur. J. Life Sci."},{"key":"95792_CR24","doi-asserted-by":"publisher","first-page":"19837","DOI":"10.1038\/s41598-024-70791-y","volume":"14","author":"E Kaya-Tilki","year":"2024","unstructured":"Kaya-Tilki, E., \u00d6zt\u00fcrk, A. A., Eng\u00fcr-\u00d6zt\u00fcrk, S. & Dikmen, M. Enhanced anti-angiogenic effects of aprepitant-loaded nanoparticles in human umbilical vein endothelial cells. Sci. Rep. 14, 19837 (2024).","journal-title":"Sci. Rep."},{"key":"95792_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/pharmaceutics13020213","volume":"13","author":"A Alshetaili","year":"2021","unstructured":"Alshetaili, A., Almutairy, B. K., Alshehri, S. M. & Repka, M. A. Development and characterization of sustained-released donepezil hydrochloride solid dispersions using hot melt extrusion technology. Pharmaceutics 13, 213 (2021).","journal-title":"Pharmaceutics"},{"key":"95792_CR26","doi-asserted-by":"publisher","first-page":"103139","DOI":"10.1016\/j.jddst.2022.103139","volume":"69","author":"M Ekinci","year":"2022","unstructured":"Ekinci, M., \u00d6zt\u00fcrk, A. A., Santos-Oliveira, R. & \u0130lem-\u00d6zdemir, D. The use of lamivudine-loaded PLGA nanoparticles in the diagnosis of lung cancer: Preparation, characterization, radiolabeling with 99mTc and cell binding. J. Drug Deliv Sci. Technol. 69, 103139 (2022).","journal-title":"J. Drug Deliv Sci. Technol."},{"key":"95792_CR27","first-page":"897","volume":"23","author":"AA \u00d6ZT\u00dcRK","year":"2019","unstructured":"\u00d6ZT\u00dcRK, A. A. & KIRIMLIO\u011eLU, G. Y. Preparation and in vitro characterization of lamivudine loaded nanoparticles prepared by acid and\/or ester terminated PLGA for effective oral anti-retroviral therapy. J. Res. Pharm. 23, 897\u2013913 (2019).","journal-title":"J. Res. Pharm."},{"key":"95792_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.56499\/jppres18.447_7.1.47","volume":"7","author":"AA \u00d6zt\u00fcrk","year":"2019","unstructured":"\u00d6zt\u00fcrk, A. A., \u00c7inar, N. \u0130. & Yenilmez, E. Development of nano-sized ketoprofen lysine incorporated Eudragit \u00ae S100 nanomedicine by double emulsion solvent evaporation and in vitro characterization. J. Pharm. Pharmacogn Res. 7, 47\u201358 (2019).","journal-title":"J. Pharm. Pharmacogn Res."},{"key":"95792_CR29","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1021\/acsomega.2c07232","volume":"8","author":"L Baghirova","year":"2023","unstructured":"Baghirova, L., Kaya Tilki, E. & \u00d6zt\u00fcrk, A. A. Evaluation of cell proliferation and wound healing effects of vitamin A palmitate-loaded PLGA\/chitosan-coated PLGA nanoparticles: Preparation, characterization, release, and release kinetics. ACS Omega. 8, 2658\u20132668 (2023).","journal-title":"ACS Omega"},{"key":"95792_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2174\/1386207322666181218160704","volume":"21","author":"AA \u00d6zt\u00fcrk","year":"2018","unstructured":"\u00d6zt\u00fcrk, A. A., G\u00fcnd\u00fcz, A. B. & Ozisik, O. Supervised machine learning algorithms for evaluation of solid lipid nanoparticles and particle size. Comb. Chem. High. Throughput Screen. 21, 693\u2013699 (2018).","journal-title":"Comb. Chem. High. Throughput Screen."},{"key":"95792_CR31","first-page":"1981","volume":"37","author":"AA \u00d6zt\u00fcrk","year":"2018","unstructured":"\u00d6zt\u00fcrk, A. A., Merve G\u00fcven, U., Yenilmez, E. & \u015eenel, B. Effects of different derivatives of Eudragit polymer on entrapment efficiency, in vitro dissolution, release kinetics and cell viability results on extended release flurbiprofen loaded nanomedicines. Lat Am. J. Pharm. 37, 1981\u20131992 (2018).","journal-title":"Lat Am. J. Pharm."},{"key":"95792_CR32","first-page":"1981","volume":"37","author":"A Ozturk","year":"2018","unstructured":"Ozturk, A., Yenilmez, G. \u00dc. V. E. N. U., Senel, B. & E. & Effects of different derivatives of Eudragit polymer on entrapment efficiency, in vitro dissolution, release kinetics and cell viability results on extended release flurbiprofen loaded nanomedicines. Lat. Am. J. Pharm. 37, 1981\u20131992 (2018).","journal-title":"Lat. Am. J. Pharm."},{"key":"95792_CR33","doi-asserted-by":"publisher","first-page":"11321","DOI":"10.1021\/acsomega.3c07289","volume":"9","author":"KN Ar\u0131nm\u0131\u015f","year":"2024","unstructured":"Ar\u0131nm\u0131\u015f, K. N., K\u0131yan, H. T. & Ozturk, A. A. Preparation, characterization, antioxidant activities, and determination of anti-Alzheimer effects of PLGA-based DDSs containing ferulic acid. ACS Omega. 9, 11321\u201311338 (2024).","journal-title":"ACS Omega"},{"key":"95792_CR34","first-page":"5793","volume":"7","author":"L Mart\u00edn-Banderas","year":"2012","unstructured":"Mart\u00edn-Banderas, L. et al. Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies. Int. J. Nanomed. 7, 5793 (2012).","journal-title":"Int. J. Nanomed."},{"key":"95792_CR35","unstructured":"Committee, I. C. H. & S. ICH Q2B validation of analytical procedures: Methodology. (European agency for the evaluation of medicinal products, International commission on harmonisation, London (CPMP\/ICH\/281\/95), 1996)."},{"key":"95792_CR36","unstructured":"Guideline, I. C. H. H. Validation of analytical procedures Q2 (R2) (ICH, Geneva, Switzerland, 2022)."},{"key":"95792_CR37","first-page":"81","volume":"56","author":"AA \u00d6zt\u00fcrk","year":"2018","unstructured":"\u00d6zt\u00fcrk, A. A., G\u00fcven, U. M. & Yenilmez, E. Flurbiprofen loaded gel based topical delivery system: formulation and in vitro characterization with new developed UPLC method. ACTA Pharm. Sci. 56, 81\u2013105 (2018).","journal-title":"ACTA Pharm. Sci."},{"key":"95792_CR38","doi-asserted-by":"crossref","unstructured":"\u00d6zt\u00fcrk, A. A. & Merve G\u00fcven, U. Cefaclor monohydrate loaded microemulsion formulation for topical application: Characterization with new developed UPLC method and stability study. J. Res. Pharm. 23, 426\u2013440 (2019).","DOI":"10.12991\/jrp.2019.150"},{"key":"95792_CR39","doi-asserted-by":"crossref","unstructured":"Borman, P. & Elder, D. Q2 (R1) validation of analytical procedures. ICH Qual. Guidelines 127\u2013166 (2017).","DOI":"10.1002\/9781118971147.ch5"},{"key":"95792_CR40","first-page":"111","volume":"49","author":"T \u00c7evikelli","year":"2024","unstructured":"\u00c7evikelli, T., G\u00fcven, U. M. & \u00d6zt\u00fcrk, A. A. Metronidazole loaded novel microemulsion formulation for topical delivery and characterization with validated new UPLC method. Fabad J. Pharm. Sci. 49, 111\u2013128 (2024).","journal-title":"Fabad J. Pharm. Sci."},{"key":"95792_CR41","doi-asserted-by":"crossref","unstructured":"Elmaskaya, A., Alper \u00d6zt\u00fcrk, A., B\u00fcy\u00fckk\u00f6ro\u01e7lu, G. & Yenilmez, E. Spray-dried ketoprofen lysine-incorporated PLGA nanoparticles; formulation, characterization, evaluation and cytotoxic profile. Indian J. Pharm. Sci. 81, (2019).","DOI":"10.36468\/pharmaceutical-sciences.555"},{"key":"95792_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1089\/adt.2020.1014","volume":"19","author":"A \u00d6zt\u00fcrk","year":"2021","unstructured":"\u00d6zt\u00fcrk, A., Naml\u0131, \u0130. & Ayg\u00fcl, A. Cefaclor monohydrate-loaded colon-targeted nanoparticles for use in COVID-19 dependent coinfections and intestinal symptoms: Formulation, characterization, release kinetics, and antimicrobial activity. Assay. Drug Dev. Technol. 19, 156\u2013175 (2021).","journal-title":"Assay. Drug Dev. Technol."},{"key":"95792_CR43","doi-asserted-by":"crossref","unstructured":"G\u00fcven, U. M., Yen\u0130lmez, E. & \u00d6zt\u00fcrk, A. A. & Evaluation of carvedilol-loaded Eudragit\u00ae nanoparticles. J. Res. Pharm. 24, 71\u201381 (2020).","DOI":"10.35333\/jrp.2020.116"},{"key":"95792_CR44","doi-asserted-by":"crossref","unstructured":"Zuo, J., Gao, Y., Bou-Chacra, N. & L\u00f6benberg, R. Evaluation of the DDSolver software applications. Biomed. Res. Int. (2014). (2014).","DOI":"10.1155\/2014\/204925"},{"key":"95792_CR45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","volume":"12","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 12, 263\u2013271 (2010).","journal-title":"AAPS J."},{"key":"95792_CR46","doi-asserted-by":"crossref","unstructured":"Ismailovi, N., K\u0131yan, H. T. & \u00d6zt\u00fcrk, A. A. A novel phytotherapy application: Preparation, characterization, Antiox-idant activities and determination of Anti-inflammatory effects by in vivo HET-CAM assay of chitosan-based DDSs containing endemic Helichry-sum pamphylicum PH Davis & Kupicha methanolic extract. Curr. Drug Deliv (2023).","DOI":"10.2174\/1567201820666230328122504"},{"key":"95792_CR47","doi-asserted-by":"crossref","unstructured":"Ozturk, A., Yenilmez, E., Arslan, R., \u015eenel, B. & Yazan, Y. Dexketoprofen Trometamol loaded solid lipid nanoparticles (SLNs): formulation, in vitro and in vivo evaluation. J. Res. Pharm. 24, (2020).","DOI":"10.35333\/jrp.2020.114"},{"key":"95792_CR48","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1089\/adt.2021.053","volume":"19","author":"AA \u00d6zt\u00fcrk","year":"2021","unstructured":"\u00d6zt\u00fcrk, A. A. & Arpagaus, C. Nano spray-dried drugs for oral administration: A review. Assay. Drug Dev. Technol. 19, 412\u2013441 (2021).","journal-title":"Assay. Drug Dev. Technol."},{"key":"95792_CR49","doi-asserted-by":"publisher","first-page":"101240","DOI":"10.1016\/j.jddst.2019.101240","volume":"54","author":"AA \u00d6zt\u00fcrk","year":"2019","unstructured":"\u00d6zt\u00fcrk, A. A., Ayg\u00fcl, A. & \u015eenel, B. Influence of glyceryl behenate, tripalmitin and stearic acid on the properties of clarithromycin incorporated solid lipid nanoparticles (SLNs): Formulation, characterization, antibacterial activity and cytotoxicity. J. Drug Deliv Sci. Technol. 54, 101240 (2019).","journal-title":"J. Drug Deliv Sci. Technol."},{"key":"95792_CR50","unstructured":"\u00d6zt\u00fcrk, A. A., Yenilmez, E., Arslan, R., \u015eenel, B. & Yazan, Y. Dexketoprofen trometamol-loaded kollidon\u00ae SR and eudragit\u00ae RS 100 polymeric nanoparticles: Formulation and in vitro-in vivo evaluation. Lat. Am. J. Pharm. 36, (2017)."},{"key":"95792_CR51","doi-asserted-by":"crossref","unstructured":"\u00d6zt\u00fcrk, A. A., Yenilmez, E. & Yazan, Y. Dexketoprofen trometamol-loaded eudragit\u00ae rl 100 nanoparticle formulation, characterization and release kinetics. Acta Pharm. Sci. 57, (2019).","DOI":"10.23893\/1307-2080.APS.05705"},{"key":"95792_CR52","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.2174\/1570180820666230214091500","volume":"20","author":"AA \u00d6zt\u00fcrk","year":"2023","unstructured":"\u00d6zt\u00fcrk, A. A., \u00dcnver, H. & K\u0131yan, H. T. Antioxidant and antiangiogenic effect of homoleptic palladium (II) car-boxamide complex loaded chitosan modified PLGA nanoparticles: In vitro evaluation and in vivo chick embryo chorioallantoic membrane (CAM) assay. Lett. Drug Des. Discov.  20, 1158\u20131170 (2023).","journal-title":"Lett. Drug Des. Discov."},{"key":"95792_CR53","doi-asserted-by":"publisher","first-page":"830","DOI":"10.2174\/1567201820666230125144133","volume":"20","author":"AA \u00d6zt\u00fcrk","year":"2023","unstructured":"\u00d6zt\u00fcrk, A. A., Tilki, E. K., G\u00fcven, U. M. & K\u0131yan, H. T. Ketorolac tromethamine loaded nano-spray dried nanoparticles: Preparation, characterization, cell viability, COL1A1 gene simulation and determination of anti-inflammatory activity by in vivo HET-CAM assay. Curr. Drug Deliv.  20, 830\u2013840 (2023).","journal-title":"Curr. Drug Deliv."},{"key":"95792_CR54","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4103\/0975-1483.83765","volume":"3","author":"P Ekambaram","year":"2011","unstructured":"Ekambaram, P. & Sathali, A. A. H. Formulation and evaluation of solid lipid nanoparticles of Ramipril. J. Young Pharmacists3, 216\u2013220 (2011).","journal-title":"J. Young Pharmacists"},{"key":"95792_CR55","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1080\/03639045.2019.1665061","volume":"45","author":"B \u015eenel","year":"2019","unstructured":"\u015eenel, B. & \u00d6zt\u00fcrk, A. A. New approaches to tumor therapy with siRNA-decorated and chitosan-modified PLGA nanoparticles. Drug Dev. Ind. Pharm. 45, 1835\u20131848 (2019).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"95792_CR56","first-page":"924","volume":"4","author":"MB Zirak","year":"2015","unstructured":"Zirak, M. B. & Pezeshki, A. Effect of surfactant concentration on the particle size, stability and potential zeta of beta carotene nano lipid carrier. Int. J. Curr. Microbiol. Appl. Sci. 4, 924\u2013932 (2015).","journal-title":"Int. J. Curr. Microbiol. Appl. Sci."},{"key":"95792_CR57","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.nano.2009.07.008","volume":"6","author":"B Koppolu","year":"2010","unstructured":"Koppolu, B., Rahimi, M., Nattama, S., Wadajkar, A. & Nguyen, K. T. Development of multiple-layer polymeric particles for targeted and controlled drug delivery. Nanomedicine 6, 355\u2013361 (2010).","journal-title":"Nanomedicine"},{"key":"95792_CR58","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijpharm.2004.11.027","volume":"290","author":"RM Mainardes","year":"2005","unstructured":"Mainardes, R. M. & Evangelista, R. C. PLGA nanoparticles containing praziquantel: Effect of formulation variables on size distribution. Int. J. Pharm. 290, 137\u2013144 (2005).","journal-title":"Int. J. Pharm."},{"key":"95792_CR59","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1111\/jcmm.17801","volume":"27","author":"B Kurban","year":"2023","unstructured":"Kurban, B. et al. Elemi essential oil nanocapsulated drug ameliorates lung cancer via oxidative stress, apoptosis and inflammation pathway. J. Cell. Mol. Med. 27, 1887\u20131899 (2023).","journal-title":"J. Cell. Mol. Med."},{"key":"95792_CR60","doi-asserted-by":"publisher","first-page":"105314","DOI":"10.1016\/j.ejps.2020.105314","volume":"148","author":"RGR Pinheiro","year":"2020","unstructured":"Pinheiro, R. G. R. et al. Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer\u2019s disease. Eur. J. Pharm. Sci. 148, 105314 (2020).","journal-title":"Eur. J. Pharm. Sci."},{"key":"95792_CR61","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jconrel.2021.11.007","volume":"340","author":"A Revdekar","year":"2021","unstructured":"Revdekar, A. & Shende, P. Block copolymers in Alzheimer\u2019s disease therapy: A perceptive to revolutionize biomaterials. J. Controlled Release. 340, 271\u2013281 (2021).","journal-title":"J. Controlled Release"},{"key":"95792_CR62","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s12668-020-00819-w","volume":"11","author":"S Madhu","year":"2021","unstructured":"Madhu, S., Komala, M. & Pandian, P. Formulation development and characterization of withaferin-A loaded polymeric nanoparticles for Alzheimer\u2019s disease. Bionanoscience 11, 559\u2013566 (2021).","journal-title":"Bionanoscience"},{"key":"95792_CR63","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva, C. et al. Nanoparticle-mediated brain drug delivery: Overcoming blood\u2013brain barrier to treat neurodegenerative diseases. J. Controlled Release 235, 34\u201347 (2016).","journal-title":"J. Controlled Release"},{"key":"95792_CR64","first-page":"403","volume":"15","author":"N Nikandish","year":"2016","unstructured":"Nikandish, N., Hosseinzadeh, L., Azandaryani, A. H. & Derakhshandeh, K. The role of nanoparticle in brain permeability: An in-vitro BBB model. Iran. J. Pharm. Res. 15, 403 (2016).","journal-title":"Iran. J. Pharm. Res."},{"key":"95792_CR65","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/10611860400015936","volume":"12","author":"PR Lockman","year":"2004","unstructured":"Lockman, P. R., Koziara, J. M., Mumper, R. J. & Allen, D. D. Nanoparticle surface charges alter blood\u2013brain barrier integrity and permeability. J. Drug Target. 12, 635\u2013641 (2004).","journal-title":"J. Drug Target."},{"key":"95792_CR66","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu, D. et al. The blood\u2013brain barrier: Structure, regulation and drug delivery. Signal. Transduct. Target. Ther. 8, 217 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"95792_CR67","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1080\/21691401.2018.1477788","volume":"46","author":"IA Lima","year":"2018","unstructured":"Lima, I. A. et al. Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid. Artif. Cells Nanomed. Biotechnol. 46, 993\u20131002 (2018).","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"95792_CR68","first-page":"1","volume":"24","author":"AAA \u00d6zt\u00fcrk","year":"2020","unstructured":"\u00d6zt\u00fcrk, A. A. A. Design of Cefaclor monohydrate containing nanoparticles with extended antibacterial effect by nano-spray dryer: A Nanoenglobing study. J. Res. Pharm. 24, 1\u201312 (2020).","journal-title":"J. Res. Pharm."},{"key":"95792_CR69","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","volume":"50","author":"RH M\u00fcller","year":"2000","unstructured":"M\u00fcller, R. H., M\u00e4der, K. & Gohla, S. Solid lipid nanoparticles (SLN) for controlled drug delivery\u2013a review of the state of the art. Eur. J. Pharm. Biopharm. 50, 161\u2013177 (2000).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"95792_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11051-015-2875-y","volume":"17","author":"M Dur\u00e1n-Lobato","year":"2015","unstructured":"Dur\u00e1n-Lobato, M., Mart\u00edn-Banderas, L., Gon\u00e7alves, L. M. D., Fern\u00e1ndez-Ar\u00e9valo, M. & Almeida, A. J. Comparative study of chitosan-and PEG-coated lipid and PLGA nanoparticles as oral delivery systems for cannabinoids. J. Nanopart. Res. 17, 1\u201317 (2015).","journal-title":"J. Nanopart. Res."},{"key":"95792_CR71","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","volume":"58","author":"W Abdelwahed","year":"2006","unstructured":"Abdelwahed, W., Degobert, G., Stainmesse, S. & Fessi, H. Freeze-drying of nanoparticles: Formulation, process and storage considerations. Adv. Drug Deliv Rev. 58, 1688\u20131713 (2006).","journal-title":"Adv. Drug Deliv Rev."},{"key":"95792_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4314\/tjpr.v18i1.1","volume":"18","author":"AA \u00d6zt\u00fcrk","year":"2019","unstructured":"\u00d6zt\u00fcrk, A. A. et al. Dexketoprofen trometamol-loaded poly-lactic-co-glycolic acid (PLGA) nanoparticles: Preparation, in vitro characterization and cyctotoxity. Trop. J. Pharm. Res. 18, 1\u201311 (2019).","journal-title":"Trop. J. Pharm. Res."},{"key":"95792_CR73","doi-asserted-by":"publisher","first-page":"117392","DOI":"10.1016\/j.saa.2019.117392","volume":"224","author":"VK Rapalli","year":"2020","unstructured":"Rapalli, V. K. et al. UV spectrophotometric method for characterization of curcumin loaded nanostructured lipid nanocarriers in simulated conditions: Method development, in-vitro and ex-vivo applications in topical delivery. Spectrochim Acta Mol. Biomol. Spectrosc. 224, 117392 (2020).","journal-title":"Spectrochim Acta Mol. Biomol. Spectrosc."},{"key":"95792_CR74","doi-asserted-by":"publisher","first-page":"120600","DOI":"10.1016\/j.saa.2021.120600","volume":"267","author":"CK Enggi","year":"2022","unstructured":"Enggi, C. K. et al. Validation of spectrophotometric method to quantify cabotegravir in simulated vaginal fluid and porcine vaginal tissue in ex vivo permeation and retention studies from thermosensitive and mucoadhesive gels. Spectrochim Acta Mol. Biomol. Spectrosc. 267, 120600 (2022).","journal-title":"Spectrochim Acta Mol. Biomol. Spectrosc."},{"key":"95792_CR75","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s12161-021-02120-2","volume":"15","author":"VH Migues","year":"2022","unstructured":"Migues, V. H., David, J. M., Gomes, A. F. & David, J. P. Determination of soybean isoflavone by HPLC\/DAD and simple UV spectroscopic analysis: A comparative study. Food Anal. Methods. 15, 367\u2013376 (2022).","journal-title":"Food Anal. Methods"},{"key":"95792_CR76","doi-asserted-by":"crossref","unstructured":"Yenilmez, E., \u00d6zt\u00fcrk, A. & Ba\u015faran, E. Preparation and in vitro, ex vivo evaluation of benzidamine hydrochlorideloaded fast dissolving oral strip formulations: Treatment of oral mucositis due to side effects of chemotherapy and radiotherapy. Lett. Drug Des. Discov. 20, (2023).","DOI":"10.2174\/1570180820666230207122755"},{"key":"95792_CR77","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1002\/jps.20094","volume":"93","author":"J Panyam","year":"2004","unstructured":"Panyam, J., Williams, D., Dash, A., Leslie-Pelecky, D. & Labhasetwar, V. Solid\u2010state solubility influences encapsulation and release of hydrophobic drugs from PLGA\/PLA nanoparticles. J. Pharm. Sci. 93, 1804\u20131814 (2004).","journal-title":"J. Pharm. Sci."},{"key":"95792_CR78","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s10924-020-01937-y","volume":"29","author":"K AnjiReddy","year":"2021","unstructured":"AnjiReddy, K. & Karpagam, S. In vitro and in vivo evaluation of oral disintegrating nanofiber and thin-film contains hyperbranched chitosan\/donepezil for active drug delivery. J. Polym. Environ. 29, 922\u2013936 (2021).","journal-title":"J. Polym. Environ."},{"key":"95792_CR79","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1080\/00222348.2013.874310","volume":"53","author":"E Bulut","year":"2014","unstructured":"Bulut, E. & \u015eanli, O. Optimization of release conditions of Alzheimer\u2019s drug donepezil hydrochloride from sodium alginate\/sodium carboxymethyl cellulose blend microspheres. J. Macromol. Sci. Part. B. 53, 902\u2013917 (2014).","journal-title":"J. Macromolecular Sci. Part. B"},{"key":"95792_CR80","doi-asserted-by":"publisher","first-page":"103923","DOI":"10.1016\/j.jddst.2022.103923","volume":"77","author":"S Raman","year":"2022","unstructured":"Raman, S., Khan, A. A. & Mahmood, S. Nose to brain delivery of selegiline loaded PLGA\/lipid nanoparticles: Synthesis, characterisation and brain pharmacokinetics evaluation. J. Drug Deliv Sci. Technol. 77, 103923 (2022).","journal-title":"J. Drug Deliv Sci. Technol."},{"key":"95792_CR81","doi-asserted-by":"publisher","first-page":"102549","DOI":"10.1016\/j.jddst.2021.102549","volume":"63","author":"L Sutthapitaksakul","year":"2021","unstructured":"Sutthapitaksakul, L., Dass, C. R. & Sriamornsak, P. Donepezil\u2014an updated review of challenges in dosage form design. J. Drug Deliv Sci. Technol. 63, 102549 (2021).","journal-title":"J. Drug Deliv Sci. Technol."},{"key":"95792_CR82","first-page":"217","volume":"67","author":"S Dash","year":"2010","unstructured":"Dash, S., Murthy, P. N., Nath, L. & Chowdhury, P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol. Pharm. 67, 217\u2013223 (2010).","journal-title":"Acta Pol. Pharm."},{"key":"95792_CR83","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.2042-7158.1978.tb13253.x","volume":"30","author":"JA Goldsmith","year":"1978","unstructured":"Goldsmith, J. A., Randall, N. & Ross, S. D. On methods of expressing dissolution rate data. J. Pharm. Pharmacol. 30, 347\u2013349 (1978).","journal-title":"J. Pharm. Pharmacol."},{"key":"95792_CR84","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/j.2042-7158.1972.tb08930.x","volume":"24","author":"F Langenbucher","year":"1972","unstructured":"Langenbucher, F. Letters to the editor: Linearization of dissolution rate curves by the Weibull distribution. J. Pharm. Pharmacol. 24, 979\u2013981 (1972).","journal-title":"J. Pharm. Pharmacol."},{"key":"95792_CR85","doi-asserted-by":"publisher","first-page":"103991","DOI":"10.1016\/j.mvr.2020.103991","volume":"130","author":"AA \u00d6zt\u00fcrk","year":"2020","unstructured":"\u00d6zt\u00fcrk, A. A., Naml\u0131, \u0130., G\u00fcle\u00e7, K. & K\u0131yan, H. T. Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: formulation, characterization and in vivo HET-CAM analysis. Microvasc Res. 130, 103991 (2020).","journal-title":"Microvasc Res."},{"key":"95792_CR86","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/pharmaceutics11040184","volume":"11","author":"H Yang","year":"2019","unstructured":"Yang, H. et al. Design of poly (lactic-co-glycolic acid)(PLGA) nanoparticles for vaginal co-delivery of Griffithsin and Dapivirine and their synergistic effect for HIV prophylaxis. Pharmaceutics 11, 184 (2019).","journal-title":"Pharmaceutics"},{"key":"95792_CR87","first-page":"30","volume":"1","author":"G Singh","year":"2014","unstructured":"Singh, G., Kaur, T., Kaur, R. & Kaur, A. Recent biomedical applications and patents on biodegradable polymer-PLGA. Int. J. Pharmacol. Pharm. Sci. 1, 30\u201342 (2014).","journal-title":"Int. J. Pharmacol. Pharm. Sci."},{"key":"95792_CR88","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4274\/tjps.galenos.2018.34392","volume":"17","author":"GY Kirimlio\u011flu","year":"2020","unstructured":"Kirimlio\u011flu, G. Y. & \u00d6zt\u00fcrk, A. A. Levocetirizine dihydrochloride-loaded Chitosan nanoparticles: formulation and in vitro evaluation. Turk. J. Pharm. Sci. 17, 27 (2020).","journal-title":"Turk. J. Pharm. Sci."},{"key":"95792_CR89","unstructured":"Mulla Saira, M. R. N. Synthesis, isolation & and characterization of donepezil open ring impurity. Int. J. Pharm. Pharm. Sci. 5, 826\u2013829 (2013)."},{"key":"95792_CR90","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1517\/14728222.11.7.967","volume":"11","author":"RA Copeland","year":"2007","unstructured":"Copeland, R. A., Harpel, M. R. & Tummino, P. J. Targeting enzyme inhibitors in drug discovery. Expert Opin. Ther. Targets  11, 967\u2013978 (2007).","journal-title":"Expert Opin. Ther. Targets"},{"key":"95792_CR91","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","volume":"36","author":"P Anand","year":"2013","unstructured":"Anand, P. & Singh, B. A review on cholinesterase inhibitors for Alzheimer\u2019s disease. Arch. Pharm. Res. 36, 375\u2013399 (2013).","journal-title":"Arch. Pharm. Res."},{"key":"95792_CR92","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ar.10021","volume":"264","author":"D Ribatti","year":"2001","unstructured":"Ribatti, D. et al. Chorioallantoic membrane capillary bed: A useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat. Record: Offi. Publ. Am. Assoc. Anatomists  264, 317\u2013324 (2001).","journal-title":"Anat. Record: Official Publication Am. Association Anatomists"},{"key":"95792_CR93","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0006-2952(00)00529-3","volume":"61","author":"S Liekens","year":"2001","unstructured":"Liekens, S., De Clercq, E. & Neyts, J. Angiogenesis: Regulators and clinical applications. Biochem. Pharmacol. 61, 253\u2013270 (2001).","journal-title":"Biochem. Pharmacol."},{"key":"95792_CR94","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2141.2004.05291.x","volume":"128","author":"D Ribatti","year":"2005","unstructured":"Ribatti, D. The crucial role of vascular permeability factor\/vascular endothelial growth factor in angiogenesis: A historical review. Br. J. Haematol. 128, 303\u2013309 (2005).","journal-title":"Br. J. Haematol."},{"key":"95792_CR95","unstructured":"Ribatti, D. History of Research on Tumor Angiogenesis (Springer Science & Business Media, 2008)."},{"key":"95792_CR96","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mod.2016.05.003","volume":"141","author":"D Ribatti","year":"2016","unstructured":"Ribatti, D. The chick embryo chorioallantoic membrane (CAM). A multifaceted experimental model. Mech. Dev. 141, 70\u201377 (2016).","journal-title":"Mech. Dev."},{"key":"95792_CR97","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/35012132","volume":"405","author":"G Helmlinger","year":"2000","unstructured":"Helmlinger, G., Endo, M., Ferrara, N., Hlatky, L. & Jain, R. K. Formation of endothelial cell networks. Nature 405, 139\u2013141 (2000).","journal-title":"Nature"},{"key":"95792_CR98","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/ptr.1666","volume":"19","author":"DH Paper","year":"2005","unstructured":"Paper, D. H., Karall, E., Kremser, M. & Krenn, L. Comparison of the antiinflammatory effects of Drosera rotundifolia and Drosera Madagascariensis in the HET-CAM assay. Phytother. Res.: Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 19, 323\u2013326 (2005).","journal-title":"Phytother. Res.: Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv."},{"key":"95792_CR99","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/74651","volume":"6","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet, P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389\u2013395 (2000).","journal-title":"Nat. Med."},{"key":"95792_CR100","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet, P. & Jain, R. K. Angiogenesis in cancer and other diseases. Nature 407, 249\u2013257 (2000).","journal-title":"Nature"},{"key":"95792_CR101","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cell.2011.08.039","volume":"146","author":"M Potente","year":"2011","unstructured":"Potente, M., Gerhardt, H. & Carmeliet, P. Basic and therapeutic aspects of angiogenesis. Cell 146, 873\u2013887 (2011).","journal-title":"Cell"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95792-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95792-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95792-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T17:01:25Z","timestamp":1744822885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95792-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["95792"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-95792-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13184"}}